These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10778763)

  • 1. Mutual predictive value of c-erbB-2 overexpression and various prognostic factors in ductal invasive breast carcinoma.
    Jakić-Razumović J; Petrovecki M; Uzarević B; Gamulin S
    Tumori; 2000; 86(1):30-6. PubMed ID: 10778763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma.
    Erdem O; Dursun A; Coşkun U; Günel N
    Tumori; 2005; 91(1):46-52. PubMed ID: 15850004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.
    Gaci Z; Bouin-Pineau MH; Gaci M; Daban A; Ingrand P; Métayé T
    Int J Oncol; 2001 Apr; 18(4):793-800. PubMed ID: 11251176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast].
    Sánchez Salmón A; Argibay S; Arias JI; Ruibal A
    Rev Esp Med Nucl; 2005; 24(3):185-90. PubMed ID: 15847785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
    Aryandono T; Harijadi ; Ghozali A
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
    Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M
    Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma.
    Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N
    Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-erbB-2 and the "triple-state" in early breast carcinomas.
    Sivridis E; Stamos C; Fiska A; Nikolettos N; Koukourakis MI; Giatromanolaki A
    Med Oncol; 2010 Sep; 27(3):578-84. PubMed ID: 19548127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors.
    González-Vela MC; Garijo MF; Fernández F; Val-Bernal JF
    Histol Histopathol; 2001 Apr; 16(2):399-406. PubMed ID: 11332695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.
    Rudolph P; Alm P; Olsson H; Heidebrecht HJ; Fernö M; Baldetorp B; Parwaresch R
    Hum Pathol; 2001 Mar; 32(3):311-9. PubMed ID: 11274641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and predictive factors of invasive ductal breast carcinomas.
    Lialiaris TS; Georgiou G; Sivridis E; Kareli D; Tripsiannis G; Papageorgiou A; Chrisafi S; Kritsi Z; Giatromanolaki A
    J BUON; 2010; 15(1):79-88. PubMed ID: 20414932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-erbB-2 overexpression in primary breast cancer: independent prognostic factor in patients at high risk.
    Schönborn I; Zschiesche W; Spitzer E; Minguillon C; Möhner M; Ebeling K; Grosse R
    Breast Cancer Res Treat; 1994; 29(3):287-95. PubMed ID: 7914107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
    Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
    Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome.
    Joshi MG; Lee AK; Loda M; Camus MG; Pedersen C; Heatley GJ; Hughes KS
    Cancer; 1996 Feb; 77(3):490-8. PubMed ID: 8630956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer.
    Horita K; Yamaguchi A; Hirose K; Ishida M; Noriki S; Imamura Y; Fukuda M
    Eur J Histochem; 2001; 45(1):73-84. PubMed ID: 11411868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of estrogen receptor, progesterone receptor and HER2 results in concurrent ipsilateral samples with invasive breast carcinoma: a retrospective study of 246 biopsies from 119 patients.
    Singh K; Wang Y; Marketkar S; Kalife ET; Steinhoff MM
    Hum Pathol; 2017 Jul; 65():123-132. PubMed ID: 28457730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of c-erbB-2 expression in invasive ductal carcinoma of the breast.
    Horiguchi J; Iino Y; Takei H; Morishita Y
    Jpn J Clin Oncol; 1995 Aug; 25(4):119-23. PubMed ID: 7666587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.